Safety, Tolerability and Pharmacodynamic Activity of JNJ-26528398 in Healthy Male Participants

NCT01520142 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: JNJ-26528398
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC